The company hopes to treat autoimmune diseases and allergies by engineering regulatory T cells.
Carl Murphy brings more than a decade of experience managing sales teams in healthcare and other critical industries.
This is an extension of a Series A Sayata initially announced in August, bringing the round’s total to $52 million.
The oversubscribed Series C will help HDAI expand into health systems across the country.
These 11 Boston women advanced to leadership — and they have advice for how you can, too.
Berkeley Investments’ 176 Lincoln development recently received city approval.
Warnings of military aggression in cyberspace are causing concern. A managed detection and response expert discusses how to react.
We're always looking for news.
